Bertino B, Knape W A, Pytlinska M, Strauss K, Hammou J C
Laboratoire de Pathologie, Nice, France.
Anal Cell Pathol. 1994 May;6(4):377-94.
Both flow cytometry (FCM) and image cytometry (ICM) were used to assess the DNA content of 1864 lesions (benign and malignant tumors, dysplasias, dystrophies and normal tissue). In total there were 1274 cases of bladder washings and 590 fresh solid tumor specimens. Of the total number of specimens, 1737 (93.2%) were satisfactorily assessed by ICM and 1424 (76.4%) by FCM. In only 100 (5.4%) cases was the DNA content unable to be assessed by either method. When bladder washings were excluded, 99.5% of samples could be evaluated by one method or the other. Concomitant determinations with both technologies were made in 1397 cases. When comparing all evaluable cases, concordance between the ploidy measurements of FCM and ICM was 92.8% (1297 concordant cases out of 1397). When bladder washings were excluded and only solid tumors considered, the concordance was 96.1% (545 concordant cases out of 567). From the experience of applying ICM and FCM to the 1864 lesions the technical limitations of each method became evident, specifically the problems of doubtful DNA diploidy and doubtful DNA aneuploidy. When there were 'doubtful' ploidy findings, the cause was generally found to be morphologic alterations of the nuclei or differences in staining procedures employed, and often the complementary use of both FCM and ICM provided ploidy clarification in questionable cases.
流式细胞术(FCM)和图像细胞术(ICM)均用于评估1864个病变(良性和恶性肿瘤、发育异常、营养不良及正常组织)的DNA含量。共有1274例膀胱冲洗液样本和590例新鲜实体瘤标本。在所有标本中,1737例(93.2%)通过ICM得到满意评估,1424例(76.4%)通过FCM得到满意评估。仅100例(5.4%)标本两种方法均无法评估其DNA含量。排除膀胱冲洗液样本后,99.5%的样本能用其中一种方法进行评估。1397例标本同时采用两种技术进行测定。比较所有可评估病例时,FCM和ICM倍性测量结果的一致性为92.8%(1397例中有1297例结果一致)。排除膀胱冲洗液样本仅考虑实体瘤时,一致性为96.1%(567例中有545例结果一致)。从将ICM和FCM应用于这1864个病变的经验来看,每种方法的技术局限性都很明显,特别是DNA二倍体可疑和DNA非整倍体可疑的问题。当出现“可疑”倍性结果时,原因通常是细胞核的形态改变或所用染色程序的差异,而且在可疑病例中,FCM和ICM的互补使用往往能明确倍性。